Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

Over 700 patients with drug-refractory paroxysmal atrial fibrillation were randomly assigned to cryoballoon or radiofrequency ablation. Cryoballoon ablation was noninferior to radiofrequency for the composite of recurrent atrial arrhythmia, use of antiarrhythmic drugs, or repeat ablation. According...

Full description

Saved in:
Bibliographic Details
Published in:The New England journal of medicine Vol. 374; no. 23; pp. 2235 - 2245
Main Authors: Kuck, Karl-Heinz, Brugada, Josep, Fürnkranz, Alexander, Metzner, Andreas, Ouyang, Feifan, Chun, K.R. Julian, Elvan, Arif, Arentz, Thomas, Bestehorn, Kurt, Pocock, Stuart J, Albenque, Jean-Paul, Tondo, Claudio
Format: Journal Article
Language:English
Published: United States Massachusetts Medical Society 09-06-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Over 700 patients with drug-refractory paroxysmal atrial fibrillation were randomly assigned to cryoballoon or radiofrequency ablation. Cryoballoon ablation was noninferior to radiofrequency for the composite of recurrent atrial arrhythmia, use of antiarrhythmic drugs, or repeat ablation. According to a 2012 expert consensus statement, catheter ablation of drug-refractory paroxysmal atrial fibrillation is a class I level A indication, 1 and pulmonary-vein isolation is the standard approach. 1 – 3 The two most frequently used ablation technologies for pulmonary-vein isolation differ in the energy source and mode of application. The most common method is the use of radiofrequency current applied in a point-by-point mode, which leads to cellular necrosis by tissue heating; the other method is the use of cryogenic energy applied with a balloon in a single-step mode, which leads to necrosis by freezing (Figure 1). Radiofrequency ablation for atrial . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-News-2
ObjectType-Feature-3
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1602014